Axsome Therapeutics AXSM
NASDAQ AXSM
$149.11 +8.14 (+5.77%)
As of: Nov 11, 2026 · 3:59 PM EST

Axsome Therapeutics (AXSM) Other Accumulated Expenses (2015 - 2026)

Updated

Axsome Therapeutics' Other Accumulated Expenses came in at $228.64 million for Q3 2026, up 63.9% from $139.47 million a year earlier and up 11.7% from the prior quarter.

Analysis

Axsome Therapeutics (AXSM) Other Accumulated Expenses (2015 - 2026) Analysis & Trends

At the end of FY2025, Axsome Therapeutics' Other Accumulated Expenses was $150.25 million, up 103.2% from FY2024.

  • Other Accumulated Expenses has increased in each of the last three years, with a three-year compound annual growth rate of 78.2% (FY2022 to FY2025).
  • Going back by year, Other Accumulated Expenses was $73.95 million in FY2024 (+58.3%), $46.71 million in FY2023 (+76.0%) and $26.55 million in FY2022.
  • The Q3 2026 figure represents the highest quarterly Other Accumulated Expenses in data going back to Q4 2015.
  • Year-over-year, Other Accumulated Expenses has increased for 14 consecutive quarters, with growth averaging 82.4% over the last eight quarters.
  • The year-over-year growth in Other Accumulated Expenses has ranged between 58.3% (Q4 2024) and 648.2% (Q2 2023) over the last five years.
  • Business Quant data shows AXSM's Other Accumulated Expenses at $204.63 million (Q2 2026), $170.24 million (Q1 2026) and $150.25 million (Q4 2025) in the three quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Axsome Therapeutics 7.41 Bn 6.15 Bn 241.89 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 228.64 Mn
Jun 30, 2026 204.63 Mn
Mar 31, 2026 170.24 Mn
Dec 31, 2025 150.25 Mn
Sep 30, 2025 139.47 Mn
Jun 30, 2025 118.17 Mn
Mar 31, 2025 95.77 Mn
Dec 31, 2024 73.95 Mn
Sep 30, 2024 68.77 Mn
Jun 30, 2024 63.53 Mn
Mar 31, 2024 49.34 Mn
Dec 31, 2023 46.71 Mn
Sep 30, 2023 42.40 Mn
Jun 30, 2023 36.03 Mn
Mar 31, 2023 30.43 Mn
Dec 31, 2022 26.55 Mn
Sep 30, 2022 14.46 Mn
Jun 30, 2022 4.82 Mn
Sep 30, 2020 1.03 Mn
Jun 30, 2020 1.21 Mn
API Access

Axsome Therapeutics Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=AXSM&period=max&api_key=YOUR_API_KEY